Active ingredientTofogliflozinCat. No. P-T144-001CAS 903565-83-3Family · Pharmaceutical analytical standards
Tofogliflozin
An SGLT2 cotransporter inhibitor (gliflozin) for type 2 diabetes, approved in Japan in March 2014: it blocks the transporter that reabsorbs at least 90% of glucose in the kidney, so that part of it is passed in the urine. This family brings together the active ingredient.
Did you know?Among the gliflozins it is one of the most selective for SGLT2, along with empagliflozin; in its molecule the sugar part and a benzofuran ring share a single carbon atom (a spiroketal structure).
Go to the active ingredient →Active ingredientTofogliflozinCat. No. P-T144-001CAS 903565-83-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.